about
Complete cure of Fusarium solani sp. complex onychomycosis with Qs NdYAG treatment.Terbinafine induced liver injury may be asymptomatic: need for regular monitoring.Correlation of invitro susceptibility based on MICs and mutations with clinical response to terbinafine in patients with tinea corporis/crurisPerspectives on misidentification of Trichophyton interdigitale/Trichophyton mentagrophytes using internal transcribed spacer region sequencing: Urgent need to update the sequence databaseScientific rationale of antifungal drug combination, including oral itraconazole and terbinafine, in recalcitrant dermatophytosesSepsis assessment in SJS/TEN: an important point overlooked?Description of a new pigmentary demarcation line (Type I)Antifungal resistance in dermatophytes: Recent trends and therapeutic implicationsAn exploratory pilot analysis of the optimal pellet number in 100 mg of itraconazole capsule to maximize the surface area to satisfy the Noyes-Whitney equationCongenital scars: a rare presentation of neonatal lupusParameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytosesLate-onset naevus of Ota: a case series of six patientsImmunosuppressive agents for dermatological indications in the ongoing COVID 19 pandemic: rationalizing use and clinical applicabilityA prospective study on patterns of topical steroids self-use in dermatophytoses and determinants predictive of cutaneous side effects
P50
Q48200668-D47070D9-7D90-466A-BC3B-866BAF3732C9Q48278720-5D9DE490-E54B-4936-8837-FC771384234DQ57052030-009DF3B7-16D8-4A98-9AA9-CED9A471FE44Q58115458-A55624DA-98D9-4381-94E5-BA48F7FD3FAFQ90452595-824DF248-BF62-479E-AC92-E9BEE9E3C9DBQ91765174-2D8C997E-16A2-4DC5-80A7-033F1F0D4D60Q91864832-66E8EF3D-40D8-4770-A874-6ABA18325F3BQ92077918-32642222-DA58-4031-849A-29E2D149CA8BQ92197247-36635C23-00BC-4A16-A93C-38CD2DD34D4FQ92294610-DB4F3425-5243-43FC-B89A-5802C0D3D7B4Q92881410-3B60DB61-2123-4734-80AD-6A23A5B0ECA8Q93261366-41A835A3-1540-4739-AC25-90CD1AEDB4CEQ95281963-D721F350-E013-46D3-A465-B5AF7C774B25Q95657304-60AEFD4B-3D1D-4DE3-A58D-001723BB3192
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ananta Khurana
@ast
Ananta Khurana
@en
Ananta Khurana
@es
Ananta Khurana
@nl
type
label
Ananta Khurana
@ast
Ananta Khurana
@en
Ananta Khurana
@es
Ananta Khurana
@nl
prefLabel
Ananta Khurana
@ast
Ananta Khurana
@en
Ananta Khurana
@es
Ananta Khurana
@nl
P106
P31
P496
0000-0001-7020-7777